FAQ
Frequently asked questions about ChondroFiller.
Answers to common questions about ChondroFiller® liquid, in plain English.

Common questions
Answers to what people ask before contacting a clinic.
What is ChondroFiller?
ChondroFiller is a collagen implant made from purified collagen, as described in the published literature. It is injected as a liquid and sets within minutes, forming a collagen scaffold in the damaged area. The manufacturer describes it as a resorbable implant that gives your own cells a framework to move into.1,2
Does it hurt?
Every patient experiences treatment differently. Your clinical team manages pain as part of routine aftercare, and your clinician can tell you what to expect for your own treatment.
How long does it last?
What are the risks?
Will it work for me, and who decides?
Is ChondroFiller available on the NHS?
ChondroFiller is supplied to private clinics in the UK. Ask your clinic or GP about NHS options for your joint.
How much does it cost?
Clinics set their own fees; ask the clinic.
Who makes ChondroFiller?
ChondroFiller is manufactured by Meidrix Biomedicals GmbH, Esslingen, Germany.
What if I want a second opinion?
You can ask to be seen at a different clinic, including one that does not offer ChondroFiller, or ask your GP to refer you elsewhere.
What if I have a problem after treatment?
Contact the clinic that treated you.
Studies mentioned on this page
- 1.Perez-Carro L, Mendoza Alejo PR, Gutierrez Castanedo G, Menendez Solana G, Fernandez Divar JA, Galindo Rubin P, Alfonso Fernandez A. Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller. Arthroscopy Techniques, 10(7):e1669-e1675, 2021. View DOI
- 2.Meidrix Biomedicals GmbH. ChondroFiller® liquid patient education leaflet. Manufacturer publication, 2022. View source
- 3.Mazek J, Gnatowski M, Salas AP, O’Donnell JM, Domżalski M, Radzimowski J. Arthroscopic utilization of ChondroFiller gel for the treatment of hip articular cartilage defects: a cohort study with 12- to 60-month follow-up. Journal of Hip Preservation Surgery, 8(1):22, 2021. View DOI
- 4.Simeonov E. Implantation of ChondroFiller Liquid as a Scaffold Material for the Treatment of Chondral Lesions of the Knee Joint. Journal of IMAB, 30(4):5936-5941, 2024. View DOI
- 5.De Lucas Villarrubia JC, Méndez Alonso MÁ, Sanz Pérez MI, Trell Lesmes F, Panadero Tapia A. Acellular Matrix-Induced Chondrogenesis Technique Improves the Results of Chondral Lesions Associated with Femoroacetabular Impingement. Arthroscopy, 2021. View DOI
- 6.Gatti SD, Vermorel PH, Vega J, Batista J, Guelfi M. Clinical and functional outcomes of arthroscopic autologous collagen-induced chondrogenesis (ACIC) for osteochondral lesions of the talus: A retrospective case series. Journal of Experimental Orthopaedics, 13(1):e70642, 2026. View DOI
- 7.Schneider U. Controlled, randomized multicenter study to compare compatibility and safety of ChondroFiller liquid (cell free 2-component collagen gel) with microfracturing of patients with focal cartilage defects of the knee joint. Video Journal of Orthopedics Surgery, 1:1-8, 2016. View DOI
Still have a question?
For your own treatment, talk to your clinician. For a question about this website, ask us.